Literature DB >> 22503071

Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Hairong Dong1, Mila Blaivas, Michael M Wang.   

Abstract

Arteries in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) are susceptible to smooth muscle loss and fibrosis, but the molecular components underlying these dramatic vascular changes are not well characterized. The purpose of this study was to investigate the distribution of collagen isoforms in the cerebral vessels of North American CADASIL patients with classical NOTCH3 mutations. Expression of types I-VI collagen in brains obtained at autopsy from six CADASIL patients with cysteine-altering mutations in NOTCH3 was compared to control brain expression. We identified a consistent increase of types I, III, IV, and VI collagen in CADASIL brains. Strong accumulation of types I, III, IV and VI collagen was noted in all calibers of vessels, including small and medium-sized leptomeningeal arteries, small penetrating white matter arteries, and capillaries. Within leptomeningeal arteries, where we could define the three tunicae of each vessel, we found distinct collagen subtype distribution patterns in CADASIL. Types I and III collagen were largely found in either adventitial/medial or transmural locations. Type IV collagen was strictly intimal/medial. Type VI collagen was adventitial or adventitial/medial. Within the thickened penetrating arteries of CADASIL patients, all four collagens extended through most of the arterial wall. We observed increased staining of capillaries in CADASIL for types I, IV, and VI collagen. In conclusion, brain vascular collagen subtypes are increased in CADASIL in multiple layers of all sizes of arteries, with disease-specific changes most prominent in the tunica media and thickened small penetrating vessels. In diseased arteries, types I, III, and VI collagen spreads from an external location (adventitia) into the vascular media, while type IV collagen accumulates in an internal pattern (intima and media). These observations are consistent with a pathological role for collagen accumulation in the vascular media in CADASIL. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503071      PMCID: PMC3370335          DOI: 10.1016/j.brainres.2012.03.037

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

1.  Cerebral arteriolar pathology in a 32-year-old patient with CADASIL.

Authors:  Q Miao; H Kalimo; N Bogdanovic; K Kostulas; A Börjesson-Hanson; M Viitanen
Journal:  Neuropathol Appl Neurobiol       Date:  2006-08       Impact factor: 8.090

2.  Arterioles of the lenticular nucleus in CADASIL.

Authors:  Qing Miao; Timo Paloneva; Seppo Tuisku; Susanna Roine; Minna Poyhonen; Matti Viitanen; Hannu Kalimo
Journal:  Stroke       Date:  2006-07-27       Impact factor: 7.914

3.  Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.

Authors:  J Tian; J Shi; R Smallman; T Iwatsubo; D M A Mann
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

Review 4.  CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  M M Ruchoux; C A Maurage
Journal:  J Neuropathol Exp Neurol       Date:  1997-09       Impact factor: 3.685

5.  COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage.

Authors:  Katayoun Vahedi; Nathalie Kubis; Monique Boukobza; Minh Arnoult; Pascale Massin; Elisabeth Tournier-Lasserve; Marie-Germaine Bousser
Journal:  Stroke       Date:  2007-03-22       Impact factor: 7.914

6.  The natural history of CADASIL: a pooled analysis of previously published cases.

Authors:  D W Desmond; J T Moroney; T Lynch; S Chan; S S Chin; J P Mohr
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

7.  Role of COL4A1 in small-vessel disease and hemorrhagic stroke.

Authors:  Douglas B Gould; F Campbell Phalan; Saskia E van Mil; John P Sundberg; Katayoun Vahedi; Pascale Massin; Marie Germaine Bousser; Peter Heutink; Jeffrey H Miner; Elisabeth Tournier-Lasserve; Simon W M John
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

8.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Authors:  Julie A Schneider; Zoe Arvanitakis; Woojeong Bang; David A Bennett
Journal:  Neurology       Date:  2007-06-13       Impact factor: 9.910

9.  Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons.

Authors:  Julie A Schneider; Patricia A Boyle; Zoe Arvanitakis; Julia L Bienias; David A Bennett
Journal:  Ann Neurol       Date:  2007-07       Impact factor: 10.422

10.  Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL.

Authors:  W C Low; M Junna; A Börjesson-Hanson; C M Morris; T H Moss; D L Stevens; D St Clair; T Mizuno; W W Zhang; K Mykkänen; J Wahlstrom; O Andersen; H Kalimo; M Viitanen; R N Kalaria
Journal:  Brain       Date:  2007-02       Impact factor: 13.501

View more
  14 in total

1.  Vascular accumulation of the small leucine-rich proteoglycan decorin in CADASIL.

Authors:  Soo Jung Lee; Xiaojie Zhang; Michael M Wang
Journal:  Neuroreport       Date:  2014-09-10       Impact factor: 1.837

2.  The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3.

Authors:  Xiaojie Zhang; Soo Jung Lee; Marian F Young; Michael M Wang
Journal:  Transl Stroke Res       Date:  2015-01-13       Impact factor: 6.829

3.  Hydrolysis of a second Asp-Pro site at the N-terminus of NOTCH3 in inherited vascular dementia.

Authors:  Xiaojie Zhang; Soo Jung Lee; Michael M Wang
Journal:  Sci Rep       Date:  2021-08-26       Impact factor: 4.996

4.  Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3.

Authors:  Kelly Z Young; Naw May P Cartee; Magdalena I Ivanova; Michael M Wang
Journal:  Exp Neurol       Date:  2020-02-28       Impact factor: 5.330

5.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.

Authors:  Marie Monet-Leprêtre; Iman Haddad; Céline Baron-Menguy; Maï Fouillot-Panchal; Meriem Riani; Valérie Domenga-Denier; Claire Dussaule; Emmanuel Cognat; Joelle Vinh; Anne Joutel
Journal:  Brain       Date:  2013-05-06       Impact factor: 13.501

6.  Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

Authors:  John R Gatti; Xiaojie Zhang; Ejona Korcari; Soo Jung Lee; Nya Greenstone; Jon G Dean; Snehaa Maripudi; Michael M Wang
Journal:  Transl Stroke Res       Date:  2018-06-22       Impact factor: 6.829

7.  Collagen represses canonical Notch signaling and binds to Notch ectodomain.

Authors:  Xiaojie Zhang; He Meng; Michael M Wang
Journal:  Int J Biochem Cell Biol       Date:  2013-04-08       Impact factor: 5.085

8.  NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease.

Authors:  Kelly Z Young; Soo Jung Lee; Xiaojie Zhang; Naw May Pearl Cartee; Mauricio Torres; Simon G Keep; Sairisheel R Gabbireddy; Julia L Fontana; Ling Qi; Michael M Wang
Journal:  J Biol Chem       Date:  2020-01-04       Impact factor: 5.157

9.  Trans-Reduction of Cerebral Small Vessel Disease Proteins by Notch-Derived EGF-like Sequences.

Authors:  Naw May Pearl Cartee; Soo Jung Lee; Kelly Z Young; Xiaojie Zhang; Michael M Wang
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 6.208

Review 10.  Overlapping Protein Accumulation Profiles of CADASIL and CAA: Is There a Common Mechanism Driving Cerebral Small-Vessel Disease?

Authors:  Kelly Z Young; Gang Xu; Simon G Keep; Jimo Borjigin; Michael M Wang
Journal:  Am J Pathol       Date:  2020-12-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.